Dr. Katarzyna Jerzak
Claim this profileSunnybrook Health Sciences Centre
Area of expertise
Breast Cancer
Katarzyna Jerzak has run 5 trials for Breast Cancer. Some of their research focus areas include:
Brain Tumor
Katarzyna Jerzak has run 1 trial for Brain Tumor. Some of their research focus areas include:
Affiliated Hospitals
Sunnybrook Health Sciences Centre
Sunnybrook Odette Cancer Centre
Clinical Trials Katarzyna Jerzak is currently running
MRI Screening
for Brain Metastases in Breast Cancer
The goal of this multi-centre, prospective study is to assess the frequency of asymptomatic brain metastasis in patients with stage IIb or III Triple Negative or HER2 positive breast cancer. The main questions it aims to answer are: 1. What proportion of patients with stage IIb or III Triple Negative or HER2 positive breast cancer have asymptomatic brain metastases identified on a screening contrast-enhanced magnetic resonance imaging (MRI) of the brain? 2. How do patients feel about undergoing brain imaging to screen for asymptomatic brain metastasis? 3. What clinical as well as liquid and tissue-based biomarkers are associated with asymptomatic detection of brain metastasis? Participants will undergo brain imaging, provide one blood sample (for analysis of ctDNA), and complete the Testing Morbidities Index (TMI) questionnaire after imaging is done. Procedures may take place either prior to or after completion of (neo)-adjuvant systemic therapy; however, the study interventions must take place within 18 months of initial breast cancer diagnosis.
Recruiting
1 award
N/A
Tucatinib + Radiation
for Breast Cancer
The proposed study will evaluate the safety and efficacy of XRT followed by systemic therapy among patients with HER2+ metastatic breast cancer and LMD
Recruiting
1 award
Phase 2
10 criteria
More about Katarzyna Jerzak
Clinical Trial Related
2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Katarzyna Jerzak has experience with
- Placebo
- Trastuzumab
- Tucatinib
- Analysis Of Circulating Tumor DNA
- Brain Imaging
- Testing Morbidities Index
Breakdown of trials Katarzyna Jerzak has run
Breast Cancer
Breast cancer
Leptomeningeal Neoplasms
Coronary Artery Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katarzyna Jerzak specialize in?
Katarzyna Jerzak focuses on Breast Cancer and Brain Tumor. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Katarzyna Jerzak currently recruiting for clinical trials?
Yes, Katarzyna Jerzak is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Katarzyna Jerzak has studied deeply?
Yes, Katarzyna Jerzak has studied treatments such as Placebo, Trastuzumab, Tucatinib.
What is the best way to schedule an appointment with Katarzyna Jerzak?
Apply for one of the trials that Katarzyna Jerzak is conducting.
What is the office address of Katarzyna Jerzak?
The office of Katarzyna Jerzak is located at: Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5 Canada. This is the address for their practice at the Sunnybrook Health Sciences Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.